CCL21 and metabolic dysfunction-associated steatotic liver disease: Research indicates that at least 80 SLC proteins are linked to human metabolic diseases, including obesity, type 2 diabetes (T2D), non-alcoholic fatty liver disease (NAFLD), and insulin resistance-related metabolic disorders (2–4).